Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psoriasis
|
705 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Myocardial Infarction
|
680 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Alcoholic Intoxication, Chronic
|
441 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.070 | 1.000 | 7 | 2004 | 2015 | ||||
Coronary Arteriosclerosis
|
440 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Attention deficit hyperactivity disorder
|
420 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.950 | 20 | 2005 | 2017 | ||||
Carcinogenesis
|
355 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.040 | 1.000 | 4 | 2007 | 2017 | ||||
Impaired cognition
|
348 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||
Epilepsy
|
339 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||
Autism Spectrum Disorders
|
331 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.040 | 1.000 | 4 | 2009 | 2013 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.030 | 0.667 | 3 | 2014 | 2015 | ||||
Endometrial Carcinoma
|
326 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 0.800 | 5 | 2004 | 2015 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of ovary
|
315 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.030 | 0.667 | 3 | 2014 | 2015 | ||||
Carcinoma of bladder
|
309 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1 | 2016 | 2016 | |||||
Mood Disorders
|
308 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.040 | 0.500 | 4 | 2008 | 2015 | ||||
Chronic Kidney Diseases
|
306 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Depressive disorder
|
297 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.857 | 21 | 2008 | 2019 | ||||
Anxiety
|
287 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.920 | 25 | 2004 | 2019 | ||||
Cervix carcinoma
|
283 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Atherosclerosis
|
281 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Bladder Neoplasm
|
281 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1 | 2016 | 2016 | |||||
Familial (FPAH)
|
276 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Endometriosis
|
274 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||
Mental Depression
|
271 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.857 | 21 | 2008 | 2019 |